Remove Resources Supply-chain-logistics
article thumbnail

Supply chain & logistics innovation among pharma companies has dropped off in the last year

Pharmaceutical Technology

Research and innovation in supply chain & logistics in the pharmaceutical sector has declined in the last year. The most recent figures show that the number of supply chain and logistics related patent applications in the industry stood at 17 in the three months ending May - down from 21 over the same period in 2021.

98
article thumbnail

GEP Spend Category Outlook 2024

Pharma and Life Sciences Blog

GEP Spend Category Outlook 2024 Vijendra Tue, 12/12/2023 - 19:11 Your Roadmap to Smarter Spend Management in 2024 Geopolitical, economic and supply chain challenges will stick around in 2024, but don’t despair. It also offers recommendations on how they can continue delivering value for their categories amid ongoing uncertainties.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How can the pharma industry navigate issues in the global supply chain to minimise drug shortages?

pharmaphorum

Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception. While navigating changes has long been a challenge for the industry, the last two years’ events have made supply chain management significantly more difficult. Logistical challenges.

Diabetes 111
article thumbnail

Harness data to unleash power of Indian pharma industry

Express Pharma

To overcome these challenges and achieve sustainable growth, the pharma industry needs to leverage the power of data science and data analytics, which can provide insights, solutions and innovations across the entire value chain. They can help the pharma industry in various ways to improve efficiencies and outcomes.

article thumbnail

Protecting patients from substandard and falsified medicines through post-marketing surveillance

Quality Matters

The panel was titled “Securing the Downstream Supply Chain: Post-marketing Surveillance.” It helps identify any emerging, potential quality and safety concerns, risks or adverse effects and events, including the potential for SF medical products to enter the supply chain. FDA and USP in Rockville, Maryland.

article thumbnail

5 ways AI and ML are revolutionizing the pharma and biotech industry

Definitive Healthcare

Resource Type E-Books & How-To Guides Blog Special Report Webinar A (friendly) ghost in the machine: Exploring AI in medical devices AI in healthcare study AI and machine learning in healthcare Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autoplay":false,"rows":0},"sm":{"slidesToShow":2,"arrows":true,"prevArrow"

article thumbnail

Is the pharmaceutical sector realising its potential for sustainable manufacturing?

European Pharmaceutical Review

1 Every major pharmaceutical manufacturer in the UK and Ireland is investing in making their operations and supply chains more environmentally friendly. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available.